Oncogene amplification in tumor cells results in the overexpression of proteins that confer a growth advantage in 
intrachromosomally, within homogeneously staining regions (HSRs), or extrachromosomally, within double minute chromosomes (DMs). Since previous studies have shown that low concentrations of hydroxyurea (HU) can eliminate DMs, we studied the use of HU as a gene-targeting agent in tumor cells containing extrachromosomally ampl oncogenes. In a neuroendocrine cell line (COLO 320), we have shown that HU can eliminate amplified copies of c-myc located on DMs, leading to a reduction in tumorigenicity in vitro and in vivo. To determine whether the observed reduction in tumorigenicity was due to differentiation, we next investigated whether HU could induce differentiation, in HL6O cells containing extrachromosomally amplified c-myc. We compared the effects of HU, as well as two other known differentiating agents (dimethyl sulfoxide and retinoic acid), on c-myc gene copy number, c-myc expression, and differentiation in HEA0 cells containing ampled c-myc genes either on DMs or HSRs. We discovered that HU and dimethyl sufoxide reduced both c-myc gene copy number and expression and induced differentiation in cells containing c-myc amplified on DMs. These agents failed to have similar effects on HL60 cells with ampled c-myc in HSRs. By contrast, retinoic acid induced differentiation independent of the localization of amplified c-myc. These data illustrate the utility of targeting extracbhromsomal DNA to modulate tumor phenotype and reveal that both HU and dimethyl sulfoxide induce differentiation in HL6O cells through DM elation.
Gene amplification in tumor cells results in the production of multiple copies of a genomic region. Amplification of oncogenes leads to the overexpression of proteins participating in the transduction of growth-related signals and confers a growth advantage to tumor cells (1, 2) . Clinically, oncogene amplification is extremely common in human tumors and correlates with a poor prognosis for patients with ovarian cancer (HER-2/neu), breast cancer (c-myc, HER-2/neu), neuroblastoma (N-myc), or small cell lung cancer (c-myc) (3) (4) (5) (6) .
Amplified oncogenes can be located on chromosomes, within homogeneously staining regions (HSRs), or they can reside extrachromosomally either as submicroscopic elements called episomes or as larger structures called double minute chromosomes (DMs) (7) (8) (9) . DMs are paired, acentric fragments that segregate randomly at cell division and can be detected in the majority of primary tumors at biopsy (10, 11). The tendency of DMs to integrate into chromosomes during passage in vitro provides one explanation for the variable incidence of DMs in cultured cell lines (8, 10) . We and others (12, 13) have shown that the number of DMs increases after cultured cells are grown as tumors in nude mice, suggesting that DMs may encode genes that provide a growth or survival advantage in vivo. One such example is the mdm-2 gene (cloned from a murine DM), which encodes a protein that binds and inactivates wild-type p53 (14, 15) .
Genes amplified on DMs can be lost spontaneously at each cell division or can be eliminated by treatment with hydroxyurea (HU) at concentrations that do not inhibit DNA synthesis or ribonucleotide reductase (13, (16) (17) (18) (19) . The mechanism of HU-induced DM elimination is mediated by an increase in micronuclei formation, and the capture of the DMs within micronuclei (13, 20) . By contrast, HSRs are not lost during cell division or by treatment with HU and represent a "stable" form of gene amplification (13, 17) . Since DMs contain amplified genes (known and unknown) and are susceptible to elimination by HU, we have been investigating the use of HU as a gene-targeting agent in cells that contain extrachromosomally amplified c-myc genes. Previously, we showed that the elimination of DM-encoded c-myc genes from a colon cancer cell line ofneuroendocrine origin (COLO 320 DM) reduced its tumorigenicity in nude mice (13) .
Since there are many studies suggesting that overexpression of c-myc is associated with increased proliferation and reduced ability to differentiate (21, 22) (8, 23) .
In this study we show that low concentrations of HU reduce the number of c-myc-containing DMs in HL60 cells, which leads to decreased c-myc expression and induction of differentiation. Furthermore, dimethyl sulfoxide (DMSO), a well-known polar solvent, also induces differentiation by this mechanism. In contrast to HU and DMSO, retinoic acid (RA) induces differentiation in HL60 cells independent of the localization of amplified c-myc genes. These studies further establish the ability of agents that eliminate extrachromosomal DNA to alter tumor phenotype and provide a rational basis for designing innovative therapeutic strategies. (24) showed that the early HL60-DM passage contained <5% of cells with HSRs, while the late HL60-HSR passage contained <1% spreads with DMs. The HL60-HSR cells served as a control for the effects of HU on cell growth and viability.
HL60 cells were grown in RPMI 1640 medium with 10%6 fetal bovine serum and 2 mM glutamine. HU (Squibb) was added on day 0 ofeach culture at the concentrations indicated and was replaced each time the cells were passaged (13) . All cells were passaged to maintain a density of <2 million cells per ml. All-trans-(-RA (RA) (Sigma) was diluted to a final concentration of 1 AuM from a stock of 1 mM in ethanol, such that the final concentration of ethanol was <0.1%. DMSO was added at a final concentration of 1.3% (vol/vol).
Determination ofc-myc Gene Copy Number and Expression.
Genomic DNA was prepared using an SDS lysis technique (25) and the fraction of the initial c-myc copy number was determined by dot-blot hybridization to a c-myc probe (Oncor). The amount of total DNA was internally controlled by subsequent hybridization to a chicken (-actin probe (Oncor).
The ratio of c-myc to 3-actin was then calculated using a densitometer (Image 1.45) or Phosphorlmager (Molecular Dynamics) and compared to the control, to yield relative percent. Total RNA was prepared using RNAzol (Tel-Test, Friendswood, TX), and the relative amount of c-myc expression was quantitated by hybridization with a c-myc probe (Oncor). The amount of total RNA loaded was controlled by subsequent hybridization to a chicken 3-actin probe (Oncor). The ratio of c-myc to (-actin was calculated using a Phosphorlmager (Molecular Dynamics) and compared to the control, to yield relative percent.
Differentiation Analyses. Differentiation was assessed using a functional assay for mature myelocytes (23 RESULTS AND DISCUSSION Treatment of HL6O-DM Cells with HU Leads to a Reduction in c-myc Gene Copy Number. Our previous studies in COLO 320 DM cells showed that low concentrations of HU could eliminate extrachromosomally amplified c-myc genes and reduce tumorigenicity (13) . We hypothesized that the observed reduction in tumorigenicity was due to decreased c-myc expression and induction of differentiation. To investigate whether there was an inverse correlation between c-myc amplification and differentiation, we studied the effects of DM elimination on the phenotype of HL60 cells. HL60 cells can be easily assessed for differentiation and isolates are available that contain amplified c-myc genes localizing to either DMs (HL60-DM) or HSRs (HL60-HSR) (8, 23) .
We first analyzed the HU dose-response of HL60-DM and HL60-HSR cells to determine if extrachromosomally amplified c-myc genes could be eliminated. The results shown in Fig. 1 Tumorigenicity. An association between c-myc gene expression and differentiation has been suggested by the correlations between c-myc oncogene overexpression and suppression of differentiation (22, 27) and by the ability of anti-sense c-myc transcripts to induce differentiation (28, 29) . Furthermore, many classic differentiating agents are associated with a decrease in expression of c-myc (30) . We therefore investigated whether reducing c-myc copy number increased the fraction of differentiated HL60 cells. We compared the differentiation of HL60-DM and HL60-HSR cells in the presence or absence of HU. Two results emerged from the data shown in Fig. 2. (i) The incidence of differentiated cells was significantly higher in the untreated HL60-DM population than in the untreated HL60-HSR population (P = 0.003 at 14 days). This was likely due to the spontaneous loss of extrachromosomally amplified c-myc during random segregation of DMs. (ii) HU treatment increased the number of differentiated HL60-DM cells but had no effect on the HL60-HSR cells. For example, 65% of the HL60-DM cells exposed to 150 AM HU for 14 days had differentiated, compared to 8% of the untreated control (P = 0.0002). By contrast, 4% of the HL60-HSR cells treated under identical conditions differentiated, compared with 1% of the untreated control. Although we cannot establish a direct cause-andeffect relationship with this experiment, the HU induction of differentiation did parallel the concentration-and time- dependent loss of extrachromosomally amplified c-myc genes shown in Fig. 1 . This relationship was linear with a correlation coefficient (r) of >0.75. These data demonstrate that the mechanism of HU-induced differentiation is specific for cells containing extrachromosomal amplicons.
Since our previous studies in COLO 320 DM cells revealed an inverse correlation between c-myc gene copy number and both in vitro and in vivo tumorigenicity, we next determined whether HU treatment affected the ability of HL60-DM and HL60-HSR cells to form colonies in soft agar (13) . Fig. 3 shows that HU treatment produced a 75% decrease in the cloning efficiency of the HL60-DM cells (P = 0.014 at 14 days) but showed no effect on HL60-HSR cells. The time and concentration dependence were similar to that observed for the loss of c-myc gene copy number and induction of differentiation. The lack of effect of HU on the cloning efficiency of HL60-HSR cells indicated that the reduction observed in the HL60-DM cells did not result from cytotoxic effects of HU at the concentrations employed.
These results provide strong evidence to support the hypothesis that the reduced tumorigenicity of HU-treated HL60-DM cells derives from reduced oncogene copy number and resulting differentiation. DMSO (31) . The precise mechanism of action is unknown but has been hypothesized to involve effects on the cellular membrane or on the conformation of DNA (32, 33 mediated, transcriptional regulator capable of inducing differentiation in many systems (35) . The available data indicate that RA induces differentiation by direct modulation of gene expression and a rapid down-regulation of c-myc (36) . We hypothesized that RA would down-regulate c-myc gene expression regardless of the localization of amplified genes and induce differentiation equally in HL60-DM and HL60-HSR cells. Table 1 shows that DMSO produced results similar to HU and that only cells harboring DMs could be induced to differentiate. The mechanism of differentiation involved elimination of extrachromosomally amplified genes, since DMSO produced a reduction in c-myc copy number in HL60-DM cells but not in HL60-HSR cells (P = 0.0006 at 14 days). The results in Table 1 also show that RA substantially induced differentiation in both HL60-DM and HL60-HSR cells. Furthermore, no significant reduction in c-myc copy number was observed in the HL60-DM cells. The fact that RA effectively differentiated the HL60-HSR cells argues against the presence of an alteration in these cells that could have produced an irreversible block to differentiation. These results confim that RA-induced differentiation is not specific to cells containing extrachromosomal DNA and consistent with a mechanism of transcriptional down-regulation of c-myc. To further investigate the mechanism of differentiation in DMSO-and HU-treated cells, we prepared metaphase spreads of HL60-DM and HL60-HSR cells and counted both the number of micronuclei and the number of DMs. The results are shown in Table 2 . Both DMSO and HU caused a reduction in the number of DMs; however, only HU induced the formation of micronuclei. Consistent with our data in COLO 320 cells, there was also some induction of micronuclei by HU in the HL60-HSR cells, but <10% contained c-myc DNA when analyzed by fluorescence in situ hybridization (data not shown). Thus, DMSO appears to eliminate c-myc-containing DMs in HL60-DM cells, but the mechanism of elimination may not be the formation of micronuclei.
Reduced Fig. 4 shows that the c-myc RNA levels decreased in the HL60-DM cells treated with either HU or DMSO but remained unchanged in the HL60-HSR cells treated in an identical fashion. In combination with the data shown in Fig. 1 and Table 1 , these data indicate that the reduction in c-myc expression produced by these agents parallels the observed changes in copy number. By contrast, RA decreased c-myc RNA levels in both HL60-DM and HSR cells without affecting copy number. As shown in Fig. 5 , the reduction in steady-state c-myc RNA correlated with an increase in differentiated cells. HU and DMSO required a longer exposure than RA to induce a maximal decrease in steady-state c-myc expression and to generate the highest fraction of differentiated cells (data not shown). The prolonged time course of HU and DMSO is consistent with a mechanism of copy number loss through cell division, whereas RA works more rapidly through a direct effect on gene expression.
These data support the evidence that overexpression of c-myc can block differentiation (22, 27) and illustrate two routes to differentiation that can reverse this blockade. We show that DMSO and HU can accelerate the loss of extrachromosomally amplified genes in HL60-DM cells, resulting in reduced c-myc expression and induction of differentiation. The lack of effect of these agents on the HL60-HSR cells indicates that the mechanism of DMSO-and HU-induced differentiation is specific to cells containing extrachromosomally amplified genes. In addition, it suggests that the chromosomal integration of amplified genes may be a mechanism whereby resistance to differentiation by this route is generated. By contrast, RA effectively differentiates both HL60-DM and HL60-HSR cells by a mechanism that is independent of the localization of amplified c-myc. Consistent with these results is a previous report showing synergistic effects on differentiation in HL60 cells with combinations of RA and either DMSO, hexamethylene bisacetamide, or sodium butyrate (37) . Our data provide a rationale to explain this observed synergism by showing that RA and DMSO function through distinct routes to induce differentiation in cells containing extrachromosomally amplified c-myc. Reduction in c-myc gene expression is the common feature of these routes to differentiation, indicating that oncogene overexpression is a significant factor in determining the phenotype of HL60 cells.
In summary, the demonstration that HU induces differentiation and reduces the cloning efficiency of HL60-DM cells is consistent with our initial hypothesis in COLO 320 DM cells. By studying the phenotypic effects of reduced copies of extrachromosomally amplified c-myc genes in COLO 320 and HL60 cells, we 
